Suncor Energy's record-breaking year in 2025 delivers Investor Day commitments one year early

All figures are approximate and in Canadian dollars, unless noted otherwiseCalgary, Alberta--(Newsfile Corp. - January 5, ...

Compass Therapeutics Provides Corporate Update

The analyses of progression-free survival (PFS) and overall survival (OS) remain on track for late Q1 2026 in the ongoing Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) ...